Acne / Rosacea - Derm-Biome Pharmaceuticals Inc.

acne / rosacea

Currently available topical acne and rosacea treatments have limited efficacy or strong side effects. Complex combination treatment regimens required to target different aspects of acne and rosacea pathophysiology lead to poor adherence, which undermines treatment success.

DB-007-4 is a new type of drug that significantly reduces the formation of acne by shutting down inflammation and eliminating pathogenic C. acnes bacteria. DB-007-4 is well-tolerated by skin.

NEWS

SCIENCE

ABOUT

Contact